Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

Chabannon, C.; Hildebrandt, M.; Scheding, S.; Humpe, A.; Lowdell, M.; Slaper-Cortenbach, I.

doi:https://doi.org/10.1038/bmt.2014.271

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

DSpace/Manakin Repository

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

Chabannon, C.; Hildebrandt, M.; Scheding, S.; Humpe, A.; Lowdell, M.; Slaper-Cortenbach, I.

(2015) Bone Marrow Transplantation, volume 50, issue 3, pp. 321 - 323

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Hematology, Transplantation, General Medicine, Editorial

DOI: https://doi.org/10.1038/bmt.2014.271

ISSN: 0268-3369

Publisher: Nature Publishing Group

(Peer reviewed)